Öйú365betÖÐÎĹÙÍø

In recent years, peptide-based therapeutics have emerged as a significant class of drugs in the pharmaceutical landscape, offering numerous advantages such as high specificity, potent activity, and relatively low toxicity. These attributes make peptides highly attractive for targeting complex diseases, including cancer, metabolic disorders, and autoimmune conditions. As the demand for innovative peptide drugs continues to grow, the need for advanced technologies and integrated approaches in early discovery becomes paramount.

In this webinar, Dr. Ma will begin by introducing peptide discovery using DNA-encoded library (DEL) technology, including a case study focused on the identification of protein–protein interaction inhibitors. He will then present WuXi AppTec’s capabilities in phage display and mRNA display, supported by corresponding case studies. In the second half, Dr. Xing will showcase the comprehensive bioassay platform and customized strategies for peptide ligand validation. Whether you're exploring peptide therapeutics for the first time or looking to expand your discovery toolkit, this session offers practical guidance and case studies to support your next breakthrough.